Regulation of inflammation and protection against invasive pneumococcal infection by the long pentraxin PTX3

  1. Rémi Porte  Is a corresponding author
  2. Rita Silva-Gomes
  3. Charlotte Theroude
  4. Raffaella Parente
  5. Fatemeh Asgari
  6. Marina Sironi
  7. Fabio Pasqualini
  8. Sonia Valentino
  9. Rosanna Asselta
  10. Camilla Recordati
  11. Marta Noemi Monari
  12. Andrea Doni
  13. Antonio Inforzato
  14. Carlos Rodriguez-Gallego
  15. Ignacio Obando
  16. Elena Colino
  17. Barbara Bottazzi  Is a corresponding author
  18. Alberto Mantovani  Is a corresponding author
  1. IRCCS Humanitas Research Hospital, Italy
  2. University Hospital of Lausanne, Switzerland
  3. Humanitas University, Italy
  4. Fondazione Filarete, Italy
  5. University Fernando Pessoa Canarias, Spain
  6. Hospital Universitario Virgen del Rocío, Spain
  7. Complejo Hospitalario Universitario Insular Materno Infantil, Spain

Abstract

Streptococcus pneumoniae is a major pathogen in children, elderly subjects and immunodeficient patients. PTX3 is a fluid phase pattern recognition molecule (PRM) involved in resistance to selected microbial agents and in regulation of inflammation. The present study was designed to assess the role of PTX3 in invasive pneumococcal infection. In a murine model of invasive pneumococcal infection, PTX3 was strongly induced in non-hematopoietic (particularly, endothelial) cells. The IL-1β/MyD88 axis played a major role in regulation of the Ptx3 gene expression. Ptx3-/- mice presented more severe invasive pneumococcal infection. Although high concentrations of PTX3 had opsonic activity in vitro, no evidence of PTX3-enhanced phagocytosis was obtained in vivo. In contrast, Ptx3-deficient mice showed enhanced recruitment of neutrophils and inflammation. Using P-selectin deficient mice, we found that protection against pneumococcus was dependent upon PTX3-mediated regulation of neutrophil inflammation. In humans, PTX3 genetic polymorphisms were associated with invasive pneumococcal infections. Thus, this fluid phase PRM plays an important role in tuning inflammation and resistance against invasive pneumococcal infection.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting file. Source Data files have been provided for Figures 1, 2, 3, 4, 5, 6, 7 and 8 and supplementary figures.

Article and author information

Author details

  1. Rémi Porte

    IRCCS Humanitas Research Hospital, Milan, Italy
    For correspondence
    remi.porte@inserm.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8311-0202
  2. Rita Silva-Gomes

    IRCCS Humanitas Research Hospital, Milan, Italy
    Competing interests
    The authors declare that no competing interests exist.
  3. Charlotte Theroude

    Infectious Diseases Service Laboratory, University Hospital of Lausanne, Epalinges, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  4. Raffaella Parente

    IRCCS Humanitas Research Hospital, Milan, Italy
    Competing interests
    The authors declare that no competing interests exist.
  5. Fatemeh Asgari

    IRCCS Humanitas Research Hospital, Milan, Italy
    Competing interests
    The authors declare that no competing interests exist.
  6. Marina Sironi

    IRCCS Humanitas Research Hospital, Milan, Italy
    Competing interests
    The authors declare that no competing interests exist.
  7. Fabio Pasqualini

    IRCCS Humanitas Research Hospital, Milan, Italy
    Competing interests
    The authors declare that no competing interests exist.
  8. Sonia Valentino

    IRCCS Humanitas Research Hospital, Milan, Italy
    Competing interests
    The authors declare that no competing interests exist.
  9. Rosanna Asselta

    Department of Biomedical Sciences, Humanitas University, Milan, Italy
    Competing interests
    The authors declare that no competing interests exist.
  10. Camilla Recordati

    Mouse and Animal Pathology Laboratory, Fondazione Filarete, Milan, Italy
    Competing interests
    The authors declare that no competing interests exist.
  11. Marta Noemi Monari

    IRCCS Humanitas Research Hospital, Milan, Italy
    Competing interests
    The authors declare that no competing interests exist.
  12. Andrea Doni

    IRCCS Humanitas Research Hospital, Milan, Italy
    Competing interests
    The authors declare that no competing interests exist.
  13. Antonio Inforzato

    IRCCS Humanitas Research Hospital, Milan, Italy
    Competing interests
    The authors declare that no competing interests exist.
  14. Carlos Rodriguez-Gallego

    Department of Clinical Sciences, University Fernando Pessoa Canarias, Las Palmas de Gran Canaria, Spain
    Competing interests
    The authors declare that no competing interests exist.
  15. Ignacio Obando

    Department of Pediatrics, Hospital Universitario Virgen del Rocío, Sevilla, Spain
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4516-1735
  16. Elena Colino

    Department of Pediatrics, Complejo Hospitalario Universitario Insular Materno Infantil, Las Palmas de Gran Canaria, Spain
    Competing interests
    The authors declare that no competing interests exist.
  17. Barbara Bottazzi

    IRCCS Humanitas Research Hospital, Milan, Italy
    For correspondence
    Barbara.Bottazzi@humanitasresearch.it
    Competing interests
    The authors declare that no competing interests exist.
  18. Alberto Mantovani

    IRCCS Humanitas Research Hospital, Milan, Italy
    For correspondence
    Alberto.Mantovani@humanitasresearch.it
    Competing interests
    The authors declare that no competing interests exist.

Funding

Fondazione Cariplo (Contract n{degree sign} 2015-0564)

  • Rémi Porte

Fondazione AIRC per la ricerca sul cancro ETS (grant IG-2019 Contract n{degree sign} 23465 and 5x1000 Contract n{degree sign} 21147)

  • Rémi Porte

HORIZON EUROPE Marie Sklodowska-Curie Actions (MSCA-ESA-ITN,grant number 676129)

  • Alberto Mantovani

Fundação para a Ciência e a Tecnologia (PD/BD/114138/2016)

  • Rita Silva-Gomes

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: Procedures involving animals handling and care were conformed to protocols approved by the Humanitas Clinical and Research Center (Rozzano, Milan, Italy) in compliance with national (4D.L. N.116, G.U., suppl. 40, 18-2-1992 and N. 26, G.U. march 4, 2014) and international law and policies (European Economic Community Council Directive 2010/63/EU, OJ L 276/33, 22.09.2010; National Institutes of Health Guide for the Care and Use of Laboratory Animals, U.S. National Research Council, 2011). All efforts were made to minimize the number of animals used and their suffering. The study was approved by the Italian Ministry of Health (742/2016-PR).

Human subjects: DNA was obtained from 57 pediatric patients with invasive pulmonary disease (IPD) and 521 age- and sex-matched healthy controls from the cohort described by Garcia-Laorden and collaborators (García-Laorden et al., 2020). DNA samples were provided by Carlos Rodriguez-Gallego, Ignacio Obando and Elena Colino .

Copyright

© 2023, Porte et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 744
    views
  • 136
    downloads
  • 8
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Rémi Porte
  2. Rita Silva-Gomes
  3. Charlotte Theroude
  4. Raffaella Parente
  5. Fatemeh Asgari
  6. Marina Sironi
  7. Fabio Pasqualini
  8. Sonia Valentino
  9. Rosanna Asselta
  10. Camilla Recordati
  11. Marta Noemi Monari
  12. Andrea Doni
  13. Antonio Inforzato
  14. Carlos Rodriguez-Gallego
  15. Ignacio Obando
  16. Elena Colino
  17. Barbara Bottazzi
  18. Alberto Mantovani
(2023)
Regulation of inflammation and protection against invasive pneumococcal infection by the long pentraxin PTX3
eLife 12:e78601.
https://doi.org/10.7554/eLife.78601

Share this article

https://doi.org/10.7554/eLife.78601

Further reading

    1. Immunology and Inflammation
    Jian Cui, Hua Li ... Congqing Wu
    Short Report

    Systemic blood coagulation accompanies inflammation during severe infections like sepsis and COVID. We previously established a link between coagulopathy and pyroptosis, a vital defense mechanism against infection. During pyroptosis, the formation of gasdermin-D (GSDMD) pores on the plasma membrane leads to the release of tissue factor (TF)-positive microvesicles (MVs) that are procoagulant. Mice lacking GSDMD release fewer of these procoagulant MVs. However, the specific mechanisms coupling the activation of GSDMD to MV release remain unclear. Plasma membrane rupture (PMR) in pyroptosis was recently reported to be actively mediated by the transmembrane protein Ninjurin-1 (NINJ1). Here, we show that NINJ1 promotes procoagulant MV release during pyroptosis. Haploinsufficiency or glycine inhibition of NINJ1 limited the release of procoagulant MVs and inflammatory cytokines, and partially protected against blood coagulation and lethality triggered by bacterial flagellin. Our findings suggest a crucial role for NINJ1-dependent PMR in inflammasome-induced blood coagulation and inflammation.

    1. Immunology and Inflammation
    2. Neuroscience
    Rocio Vicario, Stamatina Fragkogianni ... Frédéric Geissmann
    Research Article

    Somatic genetic heterogeneity resulting from post-zygotic DNA mutations is widespread in human tissues and can cause diseases, however, few studies have investigated its role in neurodegenerative processes such as Alzheimer’s disease (AD). Here, we report the selective enrichment of microglia clones carrying pathogenic variants, that are not present in neuronal, glia/stromal cells, or blood, from patients with AD in comparison to age-matched controls. Notably, microglia-specific AD-associated variants preferentially target the MAPK pathway, including recurrent CBL ring-domain mutations. These variants activate ERK and drive a microglia transcriptional program characterized by a strong neuro-inflammatory response, both in vitro and in patients. Although the natural history of AD-associated microglial clones is difficult to establish in humans, microglial expression of a MAPK pathway activating variant was previously shown to cause neurodegeneration in mice, suggesting that AD-associated neuroinflammatory microglial clones may contribute to the neurodegenerative process in patients.